Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Humana

Dow Jones Futures Rise: Market Rally Eyes Key Resistance; 5 Stocks In Buy Zones

The market rally battled back last week and futures suggest the Nasdaq will face key resistance again. Tesla and rival BYD have big news due.

Investors Business Daily

Indexes Open Higher; Retail Sales Rise More Than Expected; UnitedHealth Pops On Earnings

The Dow Jones opened higher on Friday. Stocks were up after retail sales came in strong.

Investors Business Daily

UnitedHealth Earnings Beat; UNH Stock Clears Buy Point

UnitedHealth earnings easily beat Q2 estimates and raised guidance. UNH stock moved above a buy point.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Leads Downside; Indexes Finish Lower After Surprise Inflation Data

After briefly traded higher, the S&P 500 and Nasdaq closed lower while the Dow Jones led the downside.

Investors Business Daily

3 Stocks to Target as Investors Rotate Back Into the Health Care Sector

Investors seem to show renewed interest in the healthcare sector as COVID-19 cases rise worldwide and portfolio resiliency amid the uncertain macro environment. So, fundamentally strong healthcare stocks Cigna Corp (CI), Centene Corp (CNC), and Humana (HUM) might be solid buys now. Read on.

StockNews.com

Stock Market Trades Mixed After Jobs Report; Health Care Dominates, Led By Humana And Moderna

The stock market closed mixed Friday after the jobs report indicated a tight labor market. Health care stocks led.

Investors Business Daily

Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 11.85% on an annualized basis producing an average annual return of 18.87%. Currently, Humana has a market capitalization of $59.29 billion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What Are Whales Doing With Humana

A whale with a lot of money to spend has taken a noticeably bullish stance on Humana. Looking at options history for Humana (NYSE:HUM) we detected 10 strange trades.

Benzinga

IBD Stock Of The Day Hails From Same Group For 3rd Day: Humana Flashes Buy Signals

Humana is the latest health insurer to be Stock Of The Day. HUM stock cleared early entries as it nears an official buy point from a long base.

Investors Business Daily

UnitedHealth Stock, IBD Stock Of The Day, Sets Up As Investors Play Defense

U.S. health-insurance giant UnitedHealth is the IBD Stock of the Day. UNH stock is testing resistance as it sets up in a base.

Investors Business Daily

Where Humana Stands With Analysts

Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter:

Benzinga

How Is The Market Feeling About Humana?

Humana's (NYSE:HUM) short percent of float has risen 8.42% since its last report. The company recently reported that it has 1.29 million shares sold short, which is 1.03% of all regular shares that are available for trading.

Benzinga

Humana Stock Defies Weak Market, Flashes Renewed Strength

Humana stock sees its Relative Strength Rating hit the 80-plus level.

Investors Business Daily

3 Defensive Stocks to Outperform in this Bear Market

While the stock market has entered a bear phase following the release of multi-decade high inflation data, the health insurance industry could survive the downturn because of the near-inelastic demand for health coverage. Therefore, investors looking to dodge a market downturn could bet on fundamentally sound health insurance stocks Anthem…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,500 Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.8% on an annualized basis producing an average annual return of 17.56%. Currently, Humana has a market capitalization of $53.98 billion.

Benzinga

How Is The Market Feeling About Humana?

Humana's (NYSE:HUM) short percent of float has risen 6.25% since its last report. The company recently reported that it has 1.50 million shares sold short, which is 1.19% of all regular shares that are available for trading.

Benzinga

HP And 3 Other Stocks Insiders Are Selling

US stocks closed sharply higher on Wednesday after the Federal Reserve raised its target fed funds rate by 0.5%. Investors, meanwhile, focused on some notable insider trades.

Tribune News Service

Medicare surprise: Drug plan prices touted during open enrollment can rise within a month

Something strange happened between the time Linda Griffith signed up for a new Medicare prescription drug plan during last fall’s enrollment period and when she tried to fill her first prescription in January.

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Drug plan prices touted during Medicare open enrollment can rise within a month

Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.

Benzinga

If You Invested $1000 In Humana 20 Years Ago, Here's How Much You Would Have Today

Humana (NYSE:HUM) has outperformed the market over the past 20 years by 10.96% on an annualized basis producing an average annual return of 17.93%. Currently, Humana has a market capitalization of $54.86 billion.

Investors Business Daily

Exxon Mobil, General Dynamics Lead Five Stocks Near Buy Points Without This Big Risk

Exxon Mobil and General Dynamics are among five stocks near buy points from strong groups that have already reported earnings.

Benzinga

Expert Ratings for Humana

Over the past 3 months, 6 analysts have published their opinion on Humana (NYSE:HUM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Humana's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Humana (NYSE:HUM) earned $930.00 million, a 7253.85% increase from the preceding quarter. Humana also posted a total of $24.08 billion in sales, a 13.59% increase since Q4.

Benzinga

Humana Q1 Earnings Beats Expectations, Raises FY22 Profit Guidance

Humana Inc (NYSE:HUM) has posted Q1 adjusted sales of $24.08 billion, beating the consensus of $23.51 billion. The benefits expense ratio increased from 86.4% to 85.9%, and the operating cost ratio increased from 12% to 9.7%. Humana posted an adjusted EPS of $8.04, beating the consensus of $6.78 and $6.38 posted a…

Benzinga

Humana: Q1 Earnings Insights

Humana (NYSE:HUM) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

1 … 3 4 5 6

People

Chiquita BrooksLaSure

14 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.